Kidney involvement in COVID-19 and rationale for extracorporeal therapies

The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronco, Claudio, Reis, Thiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144544/
https://www.ncbi.nlm.nih.gov/pubmed/32273593
http://dx.doi.org/10.1038/s41581-020-0284-7
Descripción
Sumario:The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood purification strategies in patients who are critically ill with COVID-19.

Ejemplares similares